FitLife Brands financials
$9.09−2.15%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 |
|---|---|---|---|
| Revenue | $15.9M | $64.5M | $52.7M |
| Gross profit | $6.9M | $28.1M | $21.4M |
| Gross margin | 43.1% | 43.6% | 40.7% |
| Operating income | $3.0M | $13.1M | $7.5M |
| Net income | $2.0M | $9.0M | $5.3M |
| Net margin | 12.7% | 13.9% | 10.0% |
| Diluted EPS | $0.20 | $0.91 | $0.54 |
| EBITDA | $3.3M | $13.5M | $9.3M |
| Operating cash flow | $7.4M | $9.6M | $4.2M |
| Free cash flow | -$35.1M | $9.6M | $4.1M |
| Diluted shares | 9.9M | 9.9M | 9.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $1.6M | $4.5M | $1.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $44.5M | $13.1M | $20.0M |
| Total assets | $106.3M | $58.5M | $55.3M |
| Total liabilities | $62.7M | $22.4M | $28.3M |
| Shareholders' equity | $43.6M | $36.1M | $27.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology